Latest Strategy News

BKI Investment Company Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.039 per share and providing key details on its Dividend Reinvestment Plan (DRP).

Tamawood Limited has reported a steady increase in revenue and profit for the half year ended December 31, 2024, signaling ongoing resilience in the residential construction sector.

VanEck Investments Limited has released detailed dividend component breakdowns for ten of its exchange traded funds for the period ending 31 January 2025, outlining key dates and tax information.

Elixir Energy Limited has had its ASX trading suspension lifted following a pivotal announcement about expanding its Taroom Trough assets and initiating a capital raise.

Elixir Energy has expanded its footprint in Queensland's Taroom Trough through a farmin deal with Santos, boosting its contingent gas resources by 68% and launching a $9 million equity raise to fund upcoming exploration activities.

Structural Monitoring Systems’ subsidiary AEM has won full US Forest Service approval for its MTP136D radio, enabling deployment across all federally regulated US aerial firefighting aircraft and setting the stage for significant growth in 2025.

Ryder Capital Limited reports a robust $13.02 million total comprehensive income for 1H FY25, driving a 12.5% increase in its fully franked interim dividend to 4.5 cents per share.

Ryder Capital Limited has reported a striking 312% increase in total comprehensive income for the half-year ended December 31, 2024, alongside a 12.5% hike in its fully franked interim dividend, underscoring robust portfolio performance amid market uncertainties.

Light & Wonder, Inc. has amended its credit agreement to increase its revolving credit facility from $750 million to $1 billion, extend the maturity to 2030, and reduce interest margins based on leverage tests, enhancing its financial flexibility.

Citigroup Global Markets Australia announces a fully franked $1.70 dividend for JBH CitiFirst Instalment MINIs, aligning with JBH Ordinary shares’ record date and ex-dividend schedule.

Memphasys has completed the final patient visit in its Felix™ clinical trial, with data lock expected within two weeks and preliminary results slated for early March 2025. This milestone paves the way for CE Mark submission and imminent commercialisation in Europe.

Elixir Energy Limited's shares have been suspended from trading pending a significant announcement about expanding its Taroom Trough position, signaling potential strategic growth in its energy assets.